Oxadiazolone Derivatives: Powerful Tools to Reduce Staphylococcus aureus Infection Forest E., Lehoux J., Faion L., Ranava D., Mohymont V., Durand T., Audebert S., Camoin L., Crauste C., Canaan S., Brunel J. M., Van Bambeke F., Bolla J.-M., Cavalier, J.-F. Staphylococcus aureus is a Gram-positive opportunistic pathogen and a top priority bacterium in the fight against antimicrobial resistance. Its high propensity to develop resistance, its high virulence, and its ability to fo

The polyamino-isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi-target inhibitors against the ESKAPEE...

Mapping of Mycobacterial Enzymes Involved in Triacylglycerol Accumulation as Intrabacterial Lipid Inclusions Using Activity-Based...

Lipolytic Enzymes Inhibitors: a new way for Antibacterial Drugs Discovery Cavalier, J.-F.; Spilling, C. D.; Durand, T.; Camoin, L.;...

LipG a bifunctional phospholipase/thioesterase involved in mycobacterial envelope remodeling Santucci, P.; Point, V.; Poncin, I.; Guy,...

Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis Nguyen, P. C.; Delorme, V.; Bénarouche, A.; Guy,...